---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-019300"
form_type: "8-K"
ticker: "FEMY"
cik: "0001339005"
company_name: "FEMASYS INC"
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:23:09.320689+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Femasys announces $3.9M registered direct offering priced at $1.22

## Summary
- Gross proceeds of ~$3.9M from sale of 3,196,722 shares (or equivalents) at $1.22; net ~$3.4M after fees.
- Warrants to purchase up to 3,196,722 shares at $1.095, exercisable immediately, term 5.5 years.
- Offering expected to close April 20, 2023; proceeds for working capital and general corporate purposes.
- Suspended ATM sales program under Equity Distribution Agreement effective April 18, 2023.
- H.C. Wainwright & Co. served as exclusive placement agent; 7.5% cash fee plus warrants.

## SEC filing metadata
- accession: 0001140361-23-019300
- form_type: 8-K
- ticker: FEMY
- cik: 0001339005
- company_name: FEMASYS INC
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1339005/000114036123019300/0001140361-23-019300-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1339005/000114036123019300/ny20008824x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-019300
- JSON: https://secwatch.observer/filing/0001140361-23-019300.json
- Plain text: https://secwatch.observer/filing/0001140361-23-019300.txt

## Key facts
- Material Agreements
  FEMASYS INC entered into Purchase Agreement with the Purchaser valued at approximately $3.9 million (effective 2023-04-18).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: the Purchaser
  - Value: approximately $3.9 million
  - Effective: 2023-04-18
  source text: On April 18, 2023, Femasys Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the purchaser identified in the Purchase Agreement (the “Purchaser”). The Purchase Agreement provides for the sale and issuance by the Company of an aggregate of: (i) 1,318,000 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (“Common Stock”), and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 1,878,722 shares (the “Pre-Funded Warrant Shares”) of Common Stock in a registered direct offering (the “Registered Offering”), and (iii) a concurrent private placement (the “Private Placement” and, together with the Registered Offering, the “Offering”) of warrants (the “Common Warrants”) to purchase up to 3,196,722 shares of Common Stock (the “Common Warrant Shares” and together with the Shares, the Pre-Funded Warrants, the Pre-Funded Warrant Shares and the Common Warrants, the “Securities”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1339005/000114036123019300/0001140361-23-019300-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.